A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML

Clinical trial NCT06329999 · RECRUITING

Trial details

NCT number: NCT06329999
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Recurrent Adult Acute Myeloid Leukemia Myelodysplastic Syndrome Adult Acute Myeloid Leukemia

Start date: 2024-02-03
Primary completion: 2025-12-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.